The microbial population of the intestinal tract is a complex natural resource that can be utilized in an effort to reduce the impact of pathogenic bacteria that affect animal production and efficiency, as well as the safety of food products. Strategies have been devised to reduce the populations of food-borne pathogenic bacteria in animals at the on-farm stage. Many of these techniques rely on harnessing the natural competitive nature of bacteria to eliminate pathogens that negatively impact animal production or food safety. Thus feed products that are classified as probiotics, prebiotics and competitive exclusion cultures have been utilized as pathogen reduction strategies in food animals with varying degrees of success. The efficacy of these products is often due to specific microbial ecological factors that alter the competitive pressures experienced by the microbial population of the gut. A few products have been shown to be effective under field conditions and many have shown indications of effectiveness under experimental conditions and as a result probiotic products are widely used in all animal species and nearly all production systems. This review explores the ecology behind the efficacy of these products against pathogens found in food animals, including those that enter the food chain and impact human consumers.
Introduction
Animals can be seriously impacted by bacterial pathogens that affect growth efficiency and overall health, as well as food safety. Several of these pathogens, such as Salmonella, can be a shared problem for both human and animal health, and have been isolated from multiple animal species. The intestinal microbial population of animals is very dense and highly diverse. More than 2000 bacterial species are known and populations >10 10 cells g À1 digesta are not uncommon (Hungate, 1966) .
The gastrointestinal microbial population slowly becomes established in the gut of animals beginning shortly after birth or hatching. As the animal matures, there is a succession of species that colonize the gut and this population slowly increases in complexity, until a stable population becomes fully established (Lu et al., 2003) . A fully mature ecosystem (including a gastrointestinal ecosystem) occupies all environmental niches and utilizes nearly all available nutrients, preventing pathogenic bacteria from obtaining a foothold in the complex gastrointestinal microbial population. As our understanding of the complexities of the gastrointestinal microbial ecosystem has grown in recent years, so has interest in using this ecosystem as a tool in our arsenal to improve animal and human health (Table 1) . Advantages of using the *Corresponding author: E-mail: todd.callaway@ars.usda.gov
Mandatory Disclaimer: 'Proprietary or brand names are necessary to report factually on available data; however, the USDA neither guarantees nor warrants the standard of the product, and the use of the name by the USDA implies no approval of the product, and/or exclusion of others that may be suitable. ' natural microbial ecosystem against the pathogens include ease of application and low economic and labor costs, and the use of a native population to reduce transient pathogens is seen as a 'green' strategy by the animal production industry. Utilization of this native or artificially introduced microflora population to improve animal health and productivity has been termed a 'probiotic', or competitive enhancement strategy (Fuller, 1989) . Competitive enhancement strategies include probiotics, prebiotics and competitive exclusion (CE) cultures and utilize the activities of the native microbial ecosystem against pathogens by capitalizing on the natural microbial competition. Each of these strategies has specific applications and limitations within each animal species, but in general, these competitive enhancement strategies offer a natural, organic and 'green' method to reduce pathogens in the gut of food animals. In this review, we will discuss the theory behind these competitive enhancement strategies, benefits, and challenges for future implementation.
Microbial ecology and pathogens
In many respects the microbial ecology within the gut can be compared with the ecology of the macrobiological world; the same selective pressures that emphasize survival fitness occur in all environments, including microbial ones. The intestinal tract is very diverse and dense, with over 2000 known species and a population of >10 10 cells g À1 digesta (Hungate, 1966; Drasar and Barrow, 1985) . Because of the extremely high intestinal population densities the competition for nutrients and environmental niches is more intense than that found in the macrobiological jungle (Steer et al., 2000) . The scale of the intestinal environment means that dietary changes and other stressors on the animal cause environmental shifts to occur more rapidly in the microbial world, necessitating an enhanced adaptability to opportunities and challenges by the bacterial inhabitants. The synergistic relationship between the host animal and its gastrointestinal microbial ecosystem is critical to the health and well being of the animal and to efficient production (Jayne-Williams and Fuller, 1971) . Recent studies have demonstrated that certain members of the microbial population of the gut (in humans, at least) can impact obesity and can cause conditions such as autism (Ley et al., 2006; DiBaise et al., 2008; Finegold, 2008) . The benefits of the microbial population in the gut of animals are due largely to the fermentation of dietary substrates to produce volatile fatty acids (VFAs) and B vitamins that are absorbed by the host animal (Branner and Roth-Maier, 2006) , but the native intestinal microbial population also stimulates the immune system (Koenen et al., 2004; Schierack et al., 2007; Walsh et al., 2008) which can reduce colonization by pathogens and subsequent illnesses. Competitive enhancement techniques that have been developed include: (1) introduction of a normal microbial population to the gastrointestinal tract (CE); (2) addition of a microbial supplement called a probiotic or a directfed-microbial (DFM), that improves gastrointestinal health and the diversity of the intestinal microbial ecology (Collins and Gibson, 1999) ; and (3) providing a specific limiting nutrient (a 'prebiotic') that allows an existing commensal microbial species or population to expand its current niche or to occupy a new niche in the gastrointestinal tract. No matter which of these strategies is employed, the overall goal is to fill all ecological niches within the gut, thereby preventing colonization by a pathogen or displacing an established pathogenic bacterial population in the gut. Competitive enhancement products have had somewhat limited applications commercially as pathogen-reduction strategies, in part due to the availability of cheap antibiotics which can counteract the effectiveness of competitive enhancement strategies (Steer et al., 2000) . Many probiotics have been used simply as methods to improve gain or enhance milk production (Stavric and Kornegay, 1995; Bomba et al., 2002) , with little or no understanding of their modes of action or reasons for inconsistencies in experimental trials (Wiemann, 2003) . Given increasing fears over the dissemination of antimicrobial resistance, it is expected that prophylactic antibiotic usage in food animals will become more closely regulated and expensive, causing probiotic/competitive enhancement strategies to become more economically feasible and widely used in disease prevention.
Probiotic studies in food animals have been characterized by inconsistency, primarily due to a lack of understanding of the microbial ecology of the gastrointestinal tract, and conditions that promote the growth of pathogens and the probiotic organisms utilized. Some probiotic species chosen for use in animals were isolated from other sources and were thus not ecologically suited for life in the anaerobic gut. Additionally, variations between studies can be attributed to antagonistic interactions between some probiotic species, as well as quality control issues. Some of this variation can also be attributed to the fact that mature animals contain a stable, relatively individualized intestinal microbial population that the probiotic must come to equilibrium with, but when probiotics are applied to neonates (or newly hatched chicks) with a sterile (or nearly so) intestinal tract, results tend to be more consistent. All of these factors have produced results that are in many cases unreplicatable. However, the advent of molecular methodologies has allowed more precise definitions of each probiotic and has allowed researchers to follow the specific changes caused by individual probiotic cultures and a greater understanding of the 'normal' gut flora and degree of individualization of the intestinal microbial ecosystem which can lead to the development of highly tailored probiotic products for use in specific animals or production environments.
CE
The bacterial species best adapted to occupy a particular niche within the intestinal tract will become the most successful and will eventually dominate the niche. An established, mature, gastrointestinal microbial population fills all available environmental niches making an animal more resistant to colonization by opportunistic bacteria, especially pathogens (Fuller, 1989) . This natural antipathogen activity has been described as 'bacterial antagonism', 'bacterial interference', or 'CE' (Nurmi and Rantala, 1973; Lloyd et al., 1974) .
CE technology involves the addition of a nonpathogenic bacterial culture of a single strain or multiple strains, to the intestinal tract of food animals in order to reduce colonization or decrease populations of pathogenic bacteria in the gastrointestinal tract (Fuller, 1989; Nurmi et al., 1992; Nisbet et al., 1993b; Steer et al., 2000) . Typically, CE cultures are isolated from the animal species that will be treated in order to take advantage of a synergistic interaction between the host animal and its native microbial ecosystem that developed during millions of years of co-evolution. The introduction of a stable, mixed microbial consortium to the naïve gut of a neonate can aid in the early establishment of a normal microbial population that can competitively prevent the establishment of a pathogenic bacterial population (Nurmi et al., 1992; Crittenden, 1999; Steer et al., 2000) . This is especially critical in the poultry industry as chicks can be quickly colonized by pathogens after hatching (Cox et al., 1990) . However, when CE is used in older animals, it must often compete against an established pathogen population that must be displaced. Therefore, the mixture of bacteria chosen for use as a CE culture must be specific for the animal, production stage, and scenario in which it will be utilized.
CE has been suggested to have several modes of action that eliminate pathogenic bacteria, including: (1) direct and indirect competition for nutrients, (2) competition for physical attachment sites, (3) production of antimicrobial compounds (including VFAs), (4) enhancement of host immune system activity, and (5) a synergistic interaction of two or more of the above activities. If bacteria (including pathogens) cannot grow at least as fast as the passage rate of their environment, then the constant flow of digesta will 'wash out' the pathogen. After a CE culture (or the natural flora) is established within the gut, bacteria bind to the surface of the intestinal epithelium (Lloyd et al., 1974) preventing opportunistic pathogens from attaching and thus obtaining a colonization foothold (Collins and Gibson, 1999) . VFAs produced by normal microbial fermentation in the gut are toxic to some pathogenic bacteria, and may reduce the competitive fitness of these bacteria in the gut environment (Wolin, 1969; Barnes et al., 1979; Prohaszka and Baron, 1983) . Additionally, some bacteria produce antimicrobial protein compounds, such as traditional antibiotics and bacteriocins or colicins that can inhibit or eliminate species competing within the same niche (Jack et al., 1995; Stahl et al., 2004; Al-Qumber and Tagg, 2006) .
In food animals, most CE research has focused on poultry (Nava et al., 2005) . This can be attributed to the need to control Salmonella colonization and production diseases in poultry, as well as the ease of application to hatched chicks with naïve gastrointestinal tracts. This has prompted CE cultures to be used widely (Stavric, 1992; Stavric and D'Aoust, 1993; Bielke et al., 2003) in many countries (Weinack et al., 1982; Fuller, 1989; Nurmi et al., 1992) . In the US, a mixed, defined commercial CE product, comprised of several defined species of bacteria (Preempt 1 , MS BioScience, Dundee, IL) was developed and used to reduce Salmonella colonization of chicks (Nisbet et al., 1993a (Nisbet et al., , 1996 . Future trade regulations are expected to increase the use of CE as a green method to reduce Salmonella on eggs and in chicks shipped into the EU.
In swine, the addition of an Enterococcus faecium culture reduced intestinal colonization by enterotoxigenic Escherichia coli (ETEC) and reduced diarrhea and mortality in experimentally infected gnotobiotic pigs (Underdahl et al., 1982) . Ushe and Nagy (1985) tested a different strain of E. faecium in ETEC-infected cesareanderived colostrum-deprived newborn pigs and observed a reduction in colonization of the ileum and in weight loss associated with the administration of E. faecium. In vitro co-cultures of the E. faecium and ETEC resulted in a lowered pH and reduced growth of the ETEC. Other researchers have found that a CE culture derived from the mucosa of healthy pigs reduced Salmonella populations in the gut of young pigs (Fedorka-Cray et al., 1999) . A swine CE culture derived from the cecal contents of healthy pigs was reported to reduce the incidence of Salmonella choleraesuis (Anderson et al., 1999; Genovese et al., 2003) . This CE culture also reduced post-weaning diarrhea, morbidity and mortality caused by ETEC, an economically important infection for the swine industry Harvey et al., 2003 Harvey et al., , 2005 . Similarly, spores of a non-toxigenic strain of Clostridium difficile given orally to piglets reduced colonization, diarrhea and growth depression from a toxigenic C. difficile (Songer et al., 2007) .
Because many pathogenic bacteria are inhibited or killed by high concentrations of VFAs, it was long thought that pathogenic E. coli would have limited opportunities to colonize cattle intestinal tracts (Hollowell and Wolin, 1965; Wolin, 1969) . However, the carriage of pathogenic E. coli O157:H7 primarily in the lower intestine of cattle has negated this hypothesis. Because of the complex microbial population of the intestinal tract, researchers have sought to utilize this environmental resource by developing CE as a strategy to eliminate E. coli O157:H7 and Salmonella from cattle (Brashears et al., 2003b; Moxley et al., 2003; Zhao et al., 2003) . Researchers isolated and defined multiple non-O157:H7 E. coli strains from cattle, and found this generic E. coli CE culture could displace an established E. coli O157:H7 population from the gastrointestinal tract of calves (Zhao et al., 1998) . While this is the only true CE culture for cattle that has been shown to reduce E. coli O157:H7, there are other probiotic cultures that target this pathogen.
Probiotics
Probiotics are a general category of dietary products that can be included in animal rations to enhance performance and/or reduce pathogenic bacteria (Fuller, 1989; Collins and Gibson, 1999) . A probiotic was initially defined as a 'live microbial feed supplement which beneficially affects the host animal by improving intestinal microbial balance' (Fuller, 1989) . In recent years, the technical definition of probiotics has been broadened to include products containing microbes or their end products (i.e. fermented dairy products, etc.) and the effect is not necessarily restricted to a change in colonization per se. A proposed definition for probiotics is 'a preparation or a product containing viable, defined micro-organisms in sufficient numbers, which alter the micro-flora (by implantation or colonization) in a compartment of the host and by that exert beneficial health effects in this host' (Schrezenmeir and De Vrese, 2001 ). Indeed, some of the probiotic products used have been shown to affect immune parameters and increase CD8 production, as well as IgG and IgM concentrations in the serum and gut of swine , Walsh et al., 2008 .
Probiotic preparations for use in animals are typically comprised of individual species or mixtures of lactic acid bacteria (LAB), yeasts, or their end products and are not species-specific, or even necessarily originally isolated from animals (Wiemann, 2003) . Probiotics often fall into the categories of: (1) live cultures of yeast or bacteria, (2) heat-treated (or otherwise inactivated) cultures of yeast or bacteria, or (3) fermentation end products from incubation of yeast or bacteria. Many probiotics are currently marketed in North America for use in both humans and animals; many of these are sold as DFM. Regulations in this field have allowed a wide variety of claims to be made about the improvements in growth efficiency and other potential benefits, and the consistency of results in the field has not always been demonstrated (LeJeune et al., 2006; Barroga et al., 2007) . However, the most commonly used probiotic bacterial strains remain Bifidobacteria and Lactobacillus, and many studies demonstrate that these types of products can enhance production efficiency (Gomes and Malcata, 1999; Barroga et al., 2007; Midilli et al., 2008) .
Some probiotics have been reported to reduce food borne pathogens and bacteria that affect growth and production in food animals (Ohya et al., 2000; Tkalcic et al., 2003; Stephens et al., 2007) . In order to prevent 220 T. R. Callaway et al.
post-weaning E. coli diarrhea in pigs (Bertschinger, 1999) , early weaning procedures and antibiotics are often used (Alexander et al., 1980; Harris, 1995, Fedorka-Cray et al., 1997) ; yet this disease is still a significant problem for the swine industry. Therefore, researchers have investigated several probiotic/DFM approaches to reducing this important production problem. Bomba et al. (1999) found that a Lactobacillus casei culture had no impact on adherence of an O8:K88 ETEC to the jejunum of experimentally infected conventional and gnotobiotic pigs. However, a mixture of the L. casei culture and maltodextrins resulted in a reduction of approximately 1 log 10 in adherence in the gnotobiotic pigs and of about 2.5 log units in the conventional pigs. The significance of these data is difficult to determine, as the concentrations of ETEC in the intestine were much lower than those usually associated with natural or experimental ETEC infections. Kyriakis et al. (2001) reported that spores of Bacillus licheniformis and Bacillus toyoi were each effective in reducing diarrhea, mortality and weight loss in a field study involving 256 weaned pigs. Supplementation of the diet of neonatal pigs with a Lactobacillus plantarum DFM resulted in an increase in total gut populations of lactobacilli in weaned pigs (Takahashi et al., 2007) . Another L. plantarum DFM product containing maltodextrin and/or fructooligosaccharides (FOS) reduced counts of E. coli O8:K88 in the jejunum and colon of piglets, and was associated with increased acetate concentrations in the ileum and colon (Nemcova et al., 2007) . Daily oral administration of E. coli strain Nissle 1917 for 10 days was reported to abolish hypersecretion by the intestine associated with experimental infection of weaned pigs with an O149:K88 strain of ETEC . Daily dosing of pigs with an E. faecium culture from birth to weaning was reported to result in a reduction in frequency of diarrhea and in improved weight gain in weaned pigs; the cause of the diarrhea was not determined (Zeyner and Boldt, 2006) . Another E. faecium DFM was found to reduce populations of Enterococcus faecalis in the colon of weaned pigs which are responsible for the onset of some cases of post-weaning diarrhea (Vahjen et al., 2007) . A recent publication reported that inclusion of a Bacillus subtilis DFM in the feed resulted in a reduction in scours 24 h after challenge of weaned pigs with a K88-positive ETEC (Bhandari et al., 2008) . Probiotics comprised of Bifidobacter lactis and Lactobacillus rhamnosus individually reduced adherence of Salmonella, E. coli and Clostridum spp. to the intestinal mucosa in swine; together the two organisms were more effective and reduced each other's adherence (Collado et al., 2007) . Reduced mucosal adhesion by pathogens is presumed to lead to reduced severity of clinical disease.
The cattle industry has used various types of probiotics for many years (Dawson et al., 1990; Gomez-Alarcon et al., 1991) . These probiotics have been primarily utilized to increase growth rate, milk production, or production efficiency (Lehloenya et al., 2008) ; however, recent years have seen the development of probiotic preparations to address other cattle health concerns. Initially, researchers compared several commercial probiotics and found that feeding probiotics provided neither benefit nor detriment in regard to food-borne pathogen levels in cattle (Keen and Elder, 2000) . Another study demonstrated that a probiotic did reduce fecal shedding of E. coli O157:H7 in sheep (Lema et al., 2001) . Since then there has been an explosion in probiotic research specifically aimed at reducing E. coli O157:H7 in cattle. A Lactobacillus acidophilus culture (a DFM) reduced E. coli O157:H7 shedding by more than 50% in finishing cattle (Brashears et al., 2003a, b) . In an independent evaluation, this DFM reduced fecal shedding of E. coli O157:H7 in cattle from 46% of animals to 13% (Ransom et al., 2003) . Further studies found that the feeding of this DFM reduced the isolation of E. coli O157:H7 from the hides of cattle by up to 75%, and the highest dose reduced Salmonella shedding in the feces by 50% (Younts-Dahl et al., 2004; Stephens et al., 2007) . This product is currently in use in many feedlots across the US and Canada because the increase in growth efficiency economically balances the cost of its inclusion in cattle rations, thus making a food safety enhancement pay for itself. In a study involving 138 feedlot steers, another DFM also reduced fecal shedding of E. coli O157:H7; shedding of Salmonella was not reduced but new Salmonella infections were reduced (Tabe et al., 2008) .
Further uses as disease preventatives in cattle have shown that the addition of bovine vaginal LAB (primarily) as a probiotic preparation inhibited the growth of metritiscausing organisms in dairy cattle (Otero et al., 2006) . Other research on probiotic preparations found that the bacteria living on the surface of a healthy udder could inhibit the in vitro growth of mastitis-causing organisms, including Arcanobacteriun pyogenes (Al-Qumber and Tagg, 2006) . Although these are not market-ready products to date, they emphasize the fact that probiotic approaches have a wide application in preventing animal diseases.
Prebiotics
Prebiotics are organic compounds that are unavailable to, or indigestible by the host animal, but are available to a specific proportion of the microbial population and are often described as 'functional foods' or 'nutraceuticals' (Schrezenmeir and de Vrese, 2001) . Prebiotics have been used as dietary supplements in humans to promote intestinal health and well-being (Crittenden, 1999) . Some carbohydrates (and other organic compounds) are not enzymatically degraded in the stomach or intestine and can be passed down to the cecum and colon to become 'colonic food' (Houdijk et al., 1998 , Kontula, 1999 .
Prebiotics provide limiting nutrients to the intestinal mucosa, as well as substrates for intestinal bacteria to ferment, yielding enhanced B vitamin production (Collins and Gibson, 1999; Crittenden, 1999; Branner and RothMaier, 2006) . Some prebiotics provide a competitive advantage to specific members of the native microflora (e.g. Bifidobacteria and Butyrivibrio) (Willard et al., 2000) that can act as a natural CE culture against pathogens. Coupling the use of CE with prebiotics is a technique known as 'synbiotics'; and this can induce a synergistic reduction of pathogens and disease (Collins and Gibson, 1999; Schrezenmeir and de Vrese, 2001) . Recent research has indicated that the use of prebiotics, such as inulin and oligofructans, can modulate activity of the immune system directly (Seifert and Watz, 2007) . Further studies found that the use of prebiotics can increase the resistance of animals to infection and the incidence of atopic dermatitis (Meyer, 2008) . A role for prebiotics has also been described in reducing inflammatory bowel disease and colitis in humans (Leenen and Dieleman, 2007; Winkler et al., 2007) .
While much of the research into prebiotics has focused on the use in humans, prebiotics have been used in the animal feed industry to improve the health and well-being of poultry, swine, horses and dogs; however, prebiotics remain relatively expensive for use in commercial animals (Mosenthin and Bauer, 2000; Willard et al., 2000; TorresRodriguez et al., 2007; Respondek et al., 2008) . The use of maltodextrins and FOS in combination with L. plantarum has been shown to reduce adherence of E. coli O8:K88 to the jejunum and colon of weaned pigs (Nemcova et al., 2007) . Galactooligosaccharides have also been demonstrated to have anti-adhesive activity, reducing the adherence of a human EPEC to the human cell lines HEp-2 and Caco-2 in a dose-dependent manner (Shoaf et al., 2006) . While the use of prebiotics in cattle has been limited due to the expense as well as the density and diversity of the ruminal microbial population and its ability to degrade most prebiotics, enhancements in rumen-protective technologies may allow these compounds to be used in feedlot and dairy cattle.
Conclusions
The diversity of the microbial population of the intestinal tract and skin is a natural resource that can be harnessed to improve animal and human health. Addition of microbial populations from healthy animals or stimulation of an existing normal flora may make it more difficult for pathogenic bacteria to become established in an environment. The primary tools for utilizing the native microbial population in the war against diseases of food animals include: CE, probiotics and prebiotics. All of these can improve animal health through a variety of mechanisms that are still not understood. However, by enhancing our knowledge of how the microbial population in and on the animal affects its growth, we can further enhance growth efficiency, productivity, food safety and animal health.
